POAI Key Statistics, Chart & Performance
The current stock price of POAI is 5.95 USD. In the past month the price decreased by -11.72%. In the past year, price decreased by -49.14%.
POAI Technical Analysis
POAI Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to POAI. Both the profitability and financial health of POAI have multiple concerns.
POAI Financial Highlights
Over the last trailing twelve months POAI reported a non-GAAP Earnings per Share(EPS) of -120.64. The EPS decreased by -163% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2688.13% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
POAI Forecast & Estimates
For the next year, analysts expect an EPS growth of 99.58% and a revenue growth 569.48% for POAI
POAI Ownership
About POAI
Company Profile
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 23 full-time employees. The company went IPO on 2009-12-18. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The firm offers a suite of solutions for oncology drug development from early discovery to clinical trials.
Company Info
PREDICTIVE ONCOLOGY INC
91 43Rd Street, Suite 110
Pittsburgh PENNSYLVANIA 55121 US
CEO: Carl Schwartz
Employees: 23
Phone: 14124321500
PREDICTIVE ONCOLOGY INC / POAI FAQ
What does PREDICTIVE ONCOLOGY INC do?
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 23 full-time employees. The company went IPO on 2009-12-18. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The firm offers a suite of solutions for oncology drug development from early discovery to clinical trials.
What is the current price of POAI stock?
The current stock price of POAI is 5.95 USD. The price increased by 0.51% in the last trading session.
Does POAI stock pay dividends?
POAI does not pay a dividend.
What is the ChartMill rating of PREDICTIVE ONCOLOGY INC stock?
POAI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the employee count for POAI stock?
PREDICTIVE ONCOLOGY INC (POAI) currently has 23 employees.